Journal of the American Chemical Society · 2004 · 68 citations · 14 references
Life SciencesBiochemistryPharmacologyDrug DiscoveryEnzymologyStructural BiologyEnzyme FunctionEnzyme InhibitionEnzyme StructureEnzyme-substrate RecognitionLigand BindingStructural EnzymologyAntimalarial AgentsAntimalarial ChemotherapyAntimalarial Drug DevelopmentElectrostatic Interactions
We have obtained the single-crystal X-ray crystallographic structures of the bisphosphonates [(1-isoquinolinylamino)methylene]-1,1-bisphosphonate and [[(5-chloro-2-pyridinyl)amino]methylene]-1,1-bisphosphonate, bound to the enzyme 1-deoxyxylulose-5-phosphate reductoisomerase (DXR, EC 1.1.1.267, also known as 2-C-methyl-d-erythritol-4-phosphate synthase), an important target for the development of antimalarial drugs. Our results indicate that both bisphosphonates bind into the fosmidomycin binding site. The aromatic groups are in a shallow hydrophobic pocket, and the phosphonate groups are involved in electrostatic interactions with Mg2+ or a cluster of carboxylic acid groups and lysine while the fosmidomycin phosphonate-binding site is occupied by a sulfate ion (as also observed in the DXR/NADP+ structure). The availability of these two new crystal structures opens up the possibility of the further development of bisphosphonates and related systems as DXR inhibitors and, potentially, as antiinfective agents.
14
VMD: Visual molecular dynamics
William Humphrey, Andrew Dalke, Klaus Schulten · Journal of Molecular Graphics · 1996 · 66.6K citations
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Hassan Jomaa, Jochen Wiesner, Silke Sanderbrand et al. · Science · 1999 · 1.2K citations
γδ T cells for immune therapy of patients with lymphoid malignancies
Martin Wilhelm, Volker Kunzmann, Susanne Eckstein et al. · Blood · 2003 · 533 citations · Full text